Back to Agenda
Session 8: Hot Topics
Session Chair(s)
Emily Place, PhD, MPH
Senior Consultant, Aclairo Pharmaceutical Development Group, United States
Ronald Wange, PhD
Principal Consultant, Aclairo Pharmaceutical Development Group, Inc., United States
Session 8: Hot Topics
Speaker(s)
Presentation Title: Harnessing RNA Exon Editing to Rewrite the Underlying Causes of Genetic Diseases
Robert Bell, PhD
CSO, Ascidian, United States
siRNA Manufacturing with Engineered Enzymes
Stefan Lutz, PhD
Chief Scientific Officer, Codexis, Inc. , United States
Confusion Arising from a Shared Vocabulary: What does “Platform” Really Mean?
Ronald Wange, PhD
Principal Consultant, Aclairo Pharmaceutical Development Group, Inc., United States
Have an account?